Empresa Amarillo Biosciences, Inc. Other OTC
Acciones
AMAR
US02301P2056
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Point-of-care Testing
100,0
%
| 4 | 100,0 % | 0 | 100,0 % | -96,53 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 4 | 100,0 % | 0 | 100,0 % | -96,53 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chun Hsien Tsai
CEO | Chief Executive Officer | 54 | 15/04/21 |
Lawrence Lin
COO | Chief Operating Officer | 55 | 01/08/21 |
Shu Ying Pan
SAM | Sales & Marketing | - | - |
Chih-Heng Lu
PRN | Corporate Officer/Principal | 44 | 11/08/21 |
Junyong Lee
LAW | General Counsel | 54 | 01/08/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Yao Chung Chiang
BRD | Director/Board Member | 70 | 15/04/21 |
Pao Sheng Wei
BRD | Director/Board Member | 66 | 15/06/22 |
Chung Yi Tsai
BRD | Director/Board Member | 47 | 15/04/21 |
Chung Jung Tsai
BRD | Director/Board Member | 52 | 15/04/21 |
Ting Chuan Lee
BRD | Director/Board Member | 40 | 15/04/21 |
Wen Han Chang
BRD | Director/Board Member | 60 | 15/04/21 |
Chun Hsien Tsai
CEO | Chief Executive Officer | 54 | 15/04/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 6 144 506 | 2 857 736 ( 46,51 %) | 0 | 46,51 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+9,42 % | 115 mil M | |
+11,84 % | 106 mil M | |
-2,85 % | 21,96 mil M | |
-14,15 % | 21,87 mil M | |
-5,29 % | 19,21 mil M | |
-4,16 % | 18,08 mil M | |
-38,29 % | 17,71 mil M | |
+7,99 % | 14,32 mil M | |
+36,24 % | 12,42 mil M |